EYPT Q1 2020 Earnings — EyePoint Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

EYPTEyePoint Pharmaceuticals, Inc.

$1B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M+272.2% YoY

Gross Profit

$7M86.9% margin

Operating Income

-$11M-152.8% margin

Net Income

-$13M-175.9% margin

EPS (Diluted)

$-1.14

QoQ Revenue Growth

-13.3%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$16M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$80M

Total Liabilities

$64M

Stockholders' Equity

$16M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$2M	+272.2%
Gross Profit	$7M	$2M	+287.0%
Operating Income	-$11M	-$15M	+21.9%
Net Income	-$13M	-$19M	+31.5%

Revenue Segments

Collaborative Research And Development

$15,000100%